Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
Study of the Combination of Binimetinib and Encorafenib in Adolescent Patients With Unresectable or Metastatic BRAF V600-mutant Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
3-month Aerobic and Resistance Exercise Intervention for Individuals Diagnosed With Melanoma
- Status
- TERMINATED
- Phase
- NA
ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS
- Status
- UNKNOWN
- Phase
- N/A
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
CAcTUS - Circulating Tumour DNA Guided Switch
- Status
- UNKNOWN
- Phase
- PHASE2
Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
- Status
- WITHDRAWN
- Phase
- N/A
Preclinical Validation of New Anti-melanoma Compounds
- Status
- COMPLETED
- Phase
- N/A
Ex Vivo Expansion of Circulating Tumor Cells as a Model for Cancer Predictive Pharmacology
- Status
- UNKNOWN
- Phase
- N/A
Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Targeted Radionuclide Therapy for Metastatic Melanoma [131I] ICF01012
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Fecal Microbial Transplantation in Combination With Immunotherapy in Melanoma Patients (MIMic)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
- Status
- COMPLETED
- Phase
- PHASE2